Clinical Trial Update: Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a maintenance strategy with protease inhibitors with or without lamivudine in virologically suppressed HIV patients on second-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lamivudine (lamivudine)
• Protease inhibitors (class)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV Infection | Phase 3 | Status: COMPLETED